Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Johnstone, R. Byhardt, D. Ettinger, C. Scott (2002)Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01
International Journal of Radiation Oncology Biology Physics, 54
L. Robinson, J. Ruckdeschel, H. Wagner, C. Stevens (2007)Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).
Chest, 132 3 Suppl
R. Arriagada, B. Bergman, A. Dunant, T. Chevalier, J. Pignon, J. Vansteenkiste (2004)Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
The New England journal of medicine, 350 4
F. Farjah, D. Wood, N. Yanez, T. Vaughan, R. Symons, Bahirathan Krishnadasan, Bahirathan Krishnadasan, D. Flum (2009)Racial disparities among patients with lung cancer who were recommended operative therapy.
Archives of surgery, 144 1
J. Albano, Elizabeth Ward, A. Jemal, Robert Anderson, V. Cokkinides, Taylor Murray, Jane Henley, J. Liff, M. Thun (2007)Cancer mortality in the United States by education level and race.
Journal of the National Cancer Institute, 99 18
Daixin Yin, C. Morris, M. Allen, R. Cress, J. Bates, Lihua Liu (2010)Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?
Cancer Causes & Control, 21
K. Schwartz, Heather Crossley-May, F. Vigneau, K. Brown, M. Banerjee (2003)Race, socioeconomic status and stage at diagnosis for five common malignancies
Cancer Causes & Control, 14
D. Farray, N. Mirković, K. Albain (2005)Multimodality therapy for stage III non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 14
J. Roth, E. Atkinson, F. Fossella, Ritsuko Komaki, M. Ryan, J. Putnam, Jin Lee, H. Dhingra, L. Caro, M. Chasen, W. Hong (1998)Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
Lung cancer, 21 1
P. Bach, L. Cramer, J. Warren, C. Begg (1999)Racial differences in the treatment of early-stage lung cancer.
The New England journal of medicine, 341 16
J. Meerbeeck, G. Kramer, P. Schil, C. Legrand, E. Smit, F. Schramel, V. Tjan-Heijnen, B. Biesma, C. Debruyne, N. Zandwijk, T. Splinter, G. Giaccone (2007)Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
Journal of the National Cancer Institute, 99 6
Relin Yang, Michael Cheung, M. Byrne, Youjie Huang, D. Nguyen, B. Lally, L. Koniaris (2010)Do racial or socioeconomic disparities exist in lung cancer treatment?
D. Argo, P. Giraud (2010)Cancer bronchique non à petites cellules
Cancer Radiotherapie, 14
C. Mountain (1997)Revisions in the International System for Staging Lung Cancer.
Chest, 111 6
Jing Li, Chunhua Dai, Shun-Bing Shi, Ping Chen, Li-chao Yu, Jian-rong Wu (2009)Prognostic factors and long term results of neo adjuvant therapy followed by surgery in stage IIIA N2 non-small cell lung cancer patients
Annals of Thoracic Medicine, 4
S. Gadgeel, R. Severson, Ying Kau, J. Graff, L. Weiss, G. Kalemkerian (2001)Impact of race in lung cancer: analysis of temporal trends from a surveillance, epidemiology, and end results database.
Chest, 120 1
D. Hardy, Chih-Chin Liu, Rui Xia, J. Cormier, W. Chan, A. White, K. Burau, Xianglin Du (2009)Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer
E. Pezzetta, R. Stupp, A. Zouhair, L. Guillou, P. Taffé, C. Briel, T. Krueger, H. Ris (2005)Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 27 6
K. Higgins, J. Chino, L. Marks, N. Ready, T. D’amico, R. Clough, C. Kelsey (2009)Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
International journal of radiation oncology, biology, physics, 75 5
Michael Thomas, C. Rübe, P. Hoffknecht, H. Macha, L. Freitag, A. Linder, N. Willich, M. Hamm, G. Sybrecht, D. Ukena, K. Deppermann, Cornelia Dröge, D. Riesenbeck, A. Heinecke, C. Sauerland, K. Junker, W. Berdel, M. Semik (2008)Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer.
The Lancet. Oncology, 9 7
M. Charlson, P. Pompei, Kathy Ales, C. MacKenzie (1987)A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
Journal of chronic diseases, 40 5
D. Johnstone, R. Byhardt, D. Ettinger, C. Scott (2002)Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
International journal of radiation oncology, biology, physics, 54 2
J. Douillard, R. Rosell, M. Lena, F. Carpagnano, R. Ramlau, J. Gonzáles-Larriba, T. Grodzki, J. Pereira, A. Groumellec, V. Lorusso, C. Clary, A. Torres, J. Dahabreh, P. Souquet, J. Astudillo, P. Fournel, A. Artal-Cortes, J. Jassem, L. Koubková, P. His, M. Riggi, P. Hurteloup (2006)Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
The Lancet. Oncology, 7 9
R. Rosell, J. Gomez-Codina, Carlos Camps, J. Sánchez, J. Maestre, José Padilla, Antonio Canto, Albert Abad, Jordi Roig (1999)Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
Lung cancer, 26 1
F. Farjah, D. Flum, S. Ramsey, P. Heagerty, R. Symons, D. Wood (2009)Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare Beneficiaries
Journal of Thoracic Oncology, 4
B. Atkins, T. D’amico (2005)Controversial issues regarding the use of induction chemotherapy for lung cancer.
Seminars in thoracic and cardiovascular surgery, 17 3
K. Chu, B. Miller, Sanya Springfield (2007)Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status.
Journal of the National Medical Association, 99 10
T. Fairley, E. Tai, J. Townsend, S. Stewart, C. Steele, S. Davis, J. Underwood (2010)Racial/Ethnic disparities and geographic differences in lung cancer incidence --- 38 States and the District of Columbia, 1998-2006.
MMWR. Morbidity and mortality weekly report, 59 44
A. Shah, M. Berry, C. Tzao, M. Gandhi, M. Worni, R. Pietrobon, T. D’amico (2012)Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer.
The Annals of thoracic surgery, 93 6
J. Warren, L. Harlan, A. Fahey, B. Virnig, J. Freeman, C. Klabunde, G. Cooper, K. Knopf (2002)Utility of the SEER-Medicare Data to Identify Chemotherapy Use
Medical Care, 40
P. Garrido, J. González-Larriba, A. Insa, M. Provencio, A. Torres, D. Isla, J. Sánchez, F. Cardenal, M. Dómine, J. Barceló, V. Tarrazona, A. Varela, R. Aguiló, J. Astudillo, I. Muguruza, Á. Artal, F. Hernando-Trancho, B. Massutí, M. Sánchez-Ronco, R. Rosell (2007)Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 30
H. Quan, V. Sundararajan, P. Halfon, A. fong, B. Burnand, J. Luthi, L. Saunders, C. Beck, T. Feasby, W. Ghali (2005)Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data
Medical Care, 43
P. Goldstraw, J. Crowley, K. Chansky, D. Giroux, P. Groome, R. Rami-Porta, P. Postmus, V. Rusch, L. Sobin (2007)The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
Journal of Thoracic Oncology, 2
J. Lund, T. Stürmer, L. Harlan, H. Sanoff, R. Sandler, M. Brookhart, J. Warren (2013)Identifying Specific Chemotherapeutic Agents in Medicare Data: A Validation Study
Medical Care, 51
Jennifer McCann, Vasken Artinian, L. Duhaime, Joseph Lewis, P. Kvale, B. Digiovine (2006)Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer.
Chest, 128 5
L. Clegg, M. Reichman, B. Miller, B. Hankey, Gopal Singh, Y. Lin, M. Goodman, C. Lynch, S. Schwartz, V. Chen, L. Bernstein, S. Gomez, J. Graff, Charles Lin, N. Johnson, B. Edwards (2008)Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study
Cancer causes & control : CCC, 20
J. Warren, C. Klabunde, D. Schrag, P. Bach, G. Riley (2002)Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population
Medical Care, 40
(2010)American Cancer Society Facts & Figures
E. Lamont, J. Herndon, J. Weeks, I. Henderson, R. Lilenbaum, R. Schilsky, N. Christakis, L. Schwartzberg, S. George, S. Grubbs, J. Kirshner, George Cannelos, M. Ernstoff, J. Crawford, R. Comis, E. Gelmann, H. Mauer, J. Kugler, Placido Ferreira, J. Polikoff, M. Citron, M. Grossbard, Mark Green, A. Lyss, L. Silverman, M. O’connell, D. Budman, W. Sikov, E. Levine, J. Goldberg, J. Atkins, J. Ellerton, C. Coltman, Arnold Rubin, S. Graziano, C. Bloomfield, R. Diasio, S. Seagren, A. Venook, G. Fleming, L. Feldman, Gerry Clamon, M. Edelman, F. Taplin, B. Peterson, M. Perry, A. Kessinger, T. Shea, H. Niell, L. Steinbrenner, H. Muss, John Roberts, D. Hurd, Joseph Drabeek, N. Bartlett, S. Wadler (2005)Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
Journal of the National Cancer Institute, 97 14
S. Gadgeel, G. Kalemkerian (2003)Racial differences in lung cancer
Cancer and Metastasis Reviews, 22
K. Albain, R. Swann, V. Rusch, A. Turrisi, Frances Shepherd, Colum Smith, Yuhchyau Chen, B. Robert, Livingston, Richard Feins, D. Gandara, Willard Fry, Gail, Darling, David Johnson, Mark Green, Robert Miller, Joanne Ley, Willliam Sause, James Cox (2009)Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
The Lancet, 374
N. Girard, F. Mornex, J. Douillard, N. Bossard, E. Quoix, V. Beckendorf, D. Grunenwald, E. Amour, B. Milleron (2010)Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trial.
Lung cancer, 69 1
N. Taylor, Z. Liao, J. Cox, C. Stevens, J. Roth, G. Walsh, Joe Chang, T. Guerrero, M. Jeter, J. Putnam, F. Fossella, P. Allen, R. Komaki (2004)Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.
International journal of radiation oncology, biology, physics, 58 1
I. Akushevich, J. Kravchenko, S. Ukraintseva, K. Arbeev, A. Yashin (2012)Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population: Medicare‐Based Analysis
Journal of the American Geriatrics Society, 60
D. Ettinger, M. Kris (2001)NCCN: Non-small cell lung cancer.
Cancer control : journal of the Moffitt Cancer Center, 8 6 Suppl 2
D. Shopland, A. Hartman, J. Gibson, Michael Mueller, L. Kessler, W. Lynn (1996)Cigarette smoking among U.S. adults by state and region: estimates from the current population survey.
Journal of the National Cancer Institute, 88 23
A. Jemal, M. Thun, L. Ries, H. Howe, H. Weir, Melissa Center, Elizabeth Ward, Xiaocheng Wu, C. Eheman, Robert Anderson, U. Ajani, B. Kohler, B. Edwards (2008)Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
JNCI Journal of the National Cancer Institute, 100
D. Hardy, Rui Xia, Chih-Chin Liu, J. Cormier, Z. Nurgalieva, Xianglin Du (2009)Racial disparities and survival for nonsmall‐cell lung cancer in a large cohort of black and white elderly patients
F. Farjah, D. Wood, D. Yanez, R. Symons, Bahirathan Krishnadasan, D. Flum (2008)Temporal trends in the management of potentially resectable lung cancer.
The Annals of thoracic surgery, 85 6
(2010)at diagnosis and survival : a population - based study in Ontario , Canada
C. Booth, Gavin Li, J. Zhang-Salomons, W. Mackillop (2010)The impact of socioeconomic status on stage of cancer at diagnosis and survival
Weian Song, N. Zhou, Wei Wang, X. Chu, Chao-yang Liang, X. Tian, Juntang Guo, Xi Liu, Yang Liu, Wei-min Dai (2010)Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials
Journal of Thoracic Oncology, 5
S. Cykert, P. Dilworth-Anderson, Michael Monroe, P. Walker, Franklin McGuire, G. Corbie-Smith, L. Edwards, Audrina Bunton (2010)Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer.
JAMA, 303 23
Original Atricle Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer Mark F. Berry, MD,* Mathias Worni, MD, MHS,*‡ Ricardo Pietrobon MD, PhD,* Thomas A. D’Amico, MD,* and Igor Akushevich, PhD† node metastases represent approximately 10% of all patients Introduction: We evaluated treatment patterns of elderly patients diagnosed with NSCLC. Multimodality therapy with some with stage IIIA (N2) non–small-cell lung cancer (NSCLC). combination of surgical resection, chemotherapy, and radia- Methods: The use of surgery, chemotherapy, and radiation for tion therapy is the preferred approach for patients with stage patients with stage IIIA (T1-T3N2M0) NSCLC in the Surveillance, IIIA (N2) NSCLC, but the optimal management strategy has Epidemiology, and End Results–Medicare database from 2004 to not been definitively established by randomized controlled 2007 was analyzed. Treatment variability was assessed using a mul- 3–7 data. In particular, the benefit of surgery when radiation and tivariable logistic regression model that included treatment, patient, 8–10 chemotherapy have been used is unclear. Induction chemo- tumor, and census track variables. Overall survival was analyzed using therapy and radiation therapy followed by surgical resection the Kaplan–Meier approach and Cox proportional hazard models. for patients with stage IIIA disease is feasible but may only Results: The most common treatments for 2958 patients with stage
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Jun 1, 2013
Access the full text.
Sign up today, get DeepDyve free for 14 days.